Cas no 298-57-7 (Cinnarizine)
Cinnarizine Chemical and Physical Properties
Names and Identifiers
-
- Stugeron
- 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazin
- 1-Benzhydryl-4-[(2E)-3-phenyl-2-propenyl]piperazine
- 1-cinnamyl-4-(diphenylmethyl)-piperazin
- 1-Cinnamyl-4-(diphenylmethyl)piperazine
- 1-cinnamyl-4-(diphenylmethyl)-Piperazine
- 1-Cinnamyl-4-diphenylmethylpiperazine
- 516 MD
- 1-TRANS-CINNAMYL-4-DIPHENYLMETHYLPIPERAZINE
- cinnarizine
- 1-Benzhydryl-4-cinnamylpiperazine
- 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
- 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine
- 桂利嗪
- Dimitronal
- Stutgin
- Stutgeron
- Mitronal
- Dimitron
- Cinarizine
- Folcodal
- Midronal
- Labyrin
- Marisan
- Glanil
- Toliman
- Lazeta
- Sepan
- Cinnarizinum
- Cinarizina
- Aplactan
- Cinnageron
- Cinazyn
- R 516
- Cinnarizinum [INN-Latin]
- Cinarizina [INN-Spanish]
- 1-Benzhydryl-4-cinnamylpiperazin
- Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-
- (E)-1-Benzhydryl-4-cinnamylpiperazine
- R 1575
- Cinnariz
- HY-B1090
- BRN 0626121
- MLS000028498
- Apotomin
- Siptazin
- CINNARIZINE [MI]
- Prestwick_115
- 1-Benzhydryl-4-[3-phenyl-2-propenyl]piperazine #
- D89561
- NCGC00018187-14
- Cerebolan
- NCGC00021488-05
- Cinnacet
- BPBio1_000172
- C 5270
- Tox21_110109
- Spaderizine
- Sedatromin
- BRD-K07220430-001-03-6
- SR-01000003093-2
- 16699-20-0
- MFCD00056037
- EINECS 206-064-8
- Aplexal
- MD 516
- MLS002207295
- NCGC00018187-04
- Cero-Aterin
- NS00006812
- 1-(diphenylmethyl)-4-(3-phenylprop-2-en-1-yl)piperazine
- Olamin
- CHEBI:31403
- Cerepar
- CAS-298-57-7
- CINNARIZINE [USAN]
- Eglen
- Katoseran
- Cinnarizine, powder
- NSC 758400
- Stunarone
- D01295
- Processine
- NCGC00018187-07
- NCGC00018187-09
- 516-MD
- CHEMBL43064
- LS-15144
- CS-4656
- Cinnarizine [USAN:INN:BAN:JAN]
- 1-(Diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine
- GTPL9072
- HMS2095H18
- Votegol
- NSC-290687
- NCGC00021488-04
- CINNARIZINE [JAN]
- CINNARIZINE [EP IMPURITY]
- 4-((2E)-3-phenylprop-2-enyl)-1-(diphenylmethyl)piperazine
- Cinnipirine
- 1185242-27-6
- BRD-K74927006-001-01-2
- CINNARIZINE [WHO-DD]
- SCHEMBL44958
- cid_1547484
- KS-5155
- HMS2234B20
- SDCCGSBI-0050302.P002
- A820077
- AKOS002134299
- NCGC00015246-02
- NCGC00018187-03
- N-Benzhydryl-N'-cinnamylpiperazine
- 1-[di(phenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine
- Stonoron
- SR-01000003093
- Piperazine, 1-cinnamyl-4-(diphenylmethyl)-
- NSC-771642
- CHEBI:131176
- NSC290687
- MLS001148649
- CINNARIZINE [MART.]
- PIPERAZINE, 1-(DIPHENYLMETHYL)-4-(3-PHENYL-2-PROPEN-1-YL)-
- N90
- DTXSID3022821
- DTXSID80859311
- Ixertol
- 1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine
- SCHEMBL44957
- HMS3260P10
- MLS002222167
- Hilactan
- W-106970
- R-516
- EU-0100314
- Q775073
- BSPBio_000156
- Piperazine, (E)-
- 1-benzhydryl-4-[(E)-cinnamyl]piperazine
- LP00314
- UNII-3DI2E1X18L
- HMS3712H18
- Cinnarizine, European Pharmacopoeia (EP) Reference Standard
- QTL1_000023
- CINNARIZINE [INN]
- Libotasin
- Artate
- Corathiem
- component of Emesazine (Salt/Mix)
- Denapol
- Prestwick2_000278
- BDBM50017657
- 3DI2E1X18L
- Tox21_500314
- L001227
- CINNARIZINE [EP MONOGRAPH]
- W-110442
- Cinaperazine
- Giganten
- HMS1568H18
- NSC771642
- SR-01000003093-6
- Prestwick3_000278
- S4727
- 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine
- Senoger
- Opera_ID_1776
- NCGC00021488-03
- SMR000058307
- HMS3885F20
- R-1575
- Carecin
- NCGC00018187-05
- CCG-204409
- BC167081
- Zepamol
- Tox21_110109_1
- DTXCID802821
- NCGC00018187-06
- Cinnarizine (JAN/USAN/INN)
- NSC-758400
- NCGC00260999-01
- EN300-18169892
- Lopac0_000314
- 298-57-7
- pound(3/4)98.0%(HPLC)(T)
- BRD-K07220430-001-19-2
- Cinnarizine?
- BRD-K07220430-001-18-4
- STK216257
- 1-(Diphenylmethyl)-4-((2E)-3-phenyl-2-propen-1-yl)piperazine
- N07CA02
- cinnarizina
- Mylan travel sickness
- HY-B1090R
- Cinnarizinum (INN-Latin)
- 5-23-01-00233 (Beilstein Handbook Reference)
- CINNARIZINE (EP MONOGRAPH)
- 206-064-8
- MD516
- DTXCID50809707
- CINNARIZINE (MART.)
- Stugeron fte
- FC20452
- Cinnarizine;Aplactan;Aplexal;1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine
- Stugeron Forte
- CINNARIZINE (EP IMPURITY)
- 1-(diphenylmethyl)-4-((2E)-3-phenylprop-2-en-1-yl)piperazine
- Marzine r.f.
- Cinarizina (INN-Spanish)
- 1-(Diphenylmethyl)-4-[(2E)-3-phenyl-2-propen-1-yl]piperazine
- 1-(di(phenyl)methyl)-4-(3-phenylprop-2-enyl)piperazine
- Cinnarizine (Standard)
- Cinnarizine
-
- MDL: MFCD00056037
- Inchi: 1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+
- InChI Key: DERZBLKQOCDDDZ-JLHYYAGUSA-N
- SMILES: N1(C(C2C=CC=CC=2)C2C=CC=CC=2)CCN(C/C=C/C2C=CC=CC=2)CC1
Computed Properties
- Exact Mass: 368.22500
- Monoisotopic Mass: 368.225248902g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 28
- Rotatable Bond Count: 6
- Complexity: 429
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- XLogP3: 5.8
- Topological Polar Surface Area: 6.5
- Surface Charge: 0
- Tautomer Count: nothing
Experimental Properties
- Color/Form: Not available
- Density: 1.1818 (rough estimate)
- Melting Point: 117.0 to 121.0 deg-C
- Boiling Point: 505.8°C at 760 mmHg
- Flash Point: 229.8±14.6 °C
- Refractive Index: 1.7620 (estimate)
- Solubility: Soluble in chloroform at 50mg/ml
- PSA: 6.48000
- LogP: 4.98280
- Vapor Pressure: 0.0±1.3 mmHg at 25°C
- Solubility: Not available
- Merck: 2305
Cinnarizine Security Information
- Signal Word:Warning
- Hazard Statement: H315; H319; H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:2
- Hazard Category Code: 20/22-36/37/38-42/43
- Safety Instruction: S22; S24/25; S36; S26
- RTECS:TL3430000
-
Hazardous Material Identification:
- Risk Phrases:R20/22
- Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
- HazardClass:9
- PackingGroup:Ⅲ
Cinnarizine Customs Data
- HS CODE:2933599090
- Customs Data:
China Customs Code:
2933599090Overview:
2933599090. Other compounds with pyrimidine ring in structure(Including other compounds with piperazine ring on the structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Cinnarizine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-B1090-10mM*1mLinDMSO |
Cinnarizine |
298-57-7 | 99.63% | 10mM*1mLinDMSO |
¥550 | 2023-07-26 | |
| MedChemExpress | HY-B1090-100mg |
Cinnarizine |
298-57-7 | 99.63% | 100mg |
¥500 | 2023-08-31 | |
| S e l l e c k ZHONG GUO | S4727-100mg |
Cinnarizine |
298-57-7 | 99.96% | 100mg |
¥795.08 | 2023-09-15 | |
| S e l l e c k ZHONG GUO | S4727-500mg |
Cinnarizine |
298-57-7 | 99.96% | 500mg |
¥2433.28 | 2023-09-15 | |
| DC Chemicals | DC9896-100 mg |
Cinnarizine |
298-57-7 | >98% | 100mg |
$180.0 | 2022-02-28 | |
| DC Chemicals | DC9896-250 mg |
Cinnarizine |
298-57-7 | >98% | 250mg |
$360.0 | 2022-02-28 | |
| DC Chemicals | DC9896-1 g |
Cinnarizine |
298-57-7 | >98% | 1g |
$720.0 | 2022-02-28 | |
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | PHR2811-200MG |
Cinnarizine |
298-57-7 | 200mg |
¥4352.22 | 2024-12-22 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | C865642-1g |
Cinnarizine |
298-57-7 | ≥98% | 1g |
¥168.00 | 2022-01-14 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | C865642-5g |
Cinnarizine |
298-57-7 | ≥98% | 5g |
¥280.00 | 2022-01-14 |
Cinnarizine Suppliers
Cinnarizine Related Literature
-
1. API ionic liquids: probing the effect of counterion structure on physical form and lipid solubilityLeigh Ford,Erin Tay,Tri-Hung Nguyen,Hywel D. Williams,Hassan Benameur,Peter J. Scammells,Christopher J. H. Porter RSC Adv. 2020 10 12788
-
Nada S. Abdelwahab,Fadwa H. Edrees,Mohammed T. Alsaadi,Noha H. Amin,Ahmed S. Saad RSC Adv. 2020 10 37439
-
Fadwa H. Edrees,Ahmed S. Saad,Mohammed T. Alsaadi,Noha H. Amin,Nada S. Abdelwahab RSC Adv. 2021 11 1450
-
4. Palladium catalyzed intermolecular hydroamination of 1-substituted allenes: an atom-economical method for the synthesis of N-allylaminesJohn F. Beck,Danielle C. Samblanet,Joseph A. R. Schmidt RSC Adv. 2013 3 20708
-
Jiangyan Jing,Xiaohong Huo,Jiefeng Shen,Jingke Fu,Qinghua Meng,Wanbin Zhang Chem. Commun. 2017 53 5151
298-57-7 (Cinnarizine) Related Products
- 52468-60-7(1-bis(4-fluorophenyl)methyl-4-(2E)-3-phenylprop-2-en-1-ylpiperazine)
- 16699-20-0(1-(diphenylmethyl)-4-(2E)-3-phenylprop-2-en-1-ylpiperazine)
- 56620-35-0(4-cinnamyl-1-[(4-chlorophenyl)benzyl]piperazinium chloride)
- 39245-23-3(Piperazine,1-[(4-chlorophenyl)phenylmethyl]-4-(3-phenyl-2-propen-1-yl)-, hydrochloride(1:2))
- 40218-96-0(Piperazine,1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propen-1-yl)-)
- 750512-44-8((Z)-Cinnarizine)
- 70713-45-0(Piperazine,1-(diphenylmethyl)-4-(2-propen-1-yl)-)
- 298-55-5(Piperazine,1-[(4-chlorophenyl)phenylmethyl]-4-(3-phenyl-2-propen-1-yl)-)
- 87887-56-7(Piperazine, 1-(diphenylmethyl)-4-(2-propenyl)-, hydrochloride)
- 1185242-27-6(Cinnarizine-d)